Crossmark

The emerging role of anti-thymic stromal lymphopoietin monoclonal antibody (Tezepelumab) in comorbid and non-comorbid CRSwNP patients: a scoping review

Crossref DOI link: https://doi.org/10.1016/j.bjorl.2026.101768

Published Print: 2026-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Moffa, Antonio https://orcid.org/0000-0002-6181-8194
de Corso, Eugenio

Nardelli, Domiziana

Loperfido, Antonella https://orcid.org/0000-0002-7174-8126
Galli, Jacopo

Baptista, Peter https://orcid.org/0000-0002-6601-5331
Casale, Manuele
License Information

Text and Data Mining valid from 2026-03-01

Text and Data Mining valid from 2026-03-01

Version of Record valid from 2026-01-14
More Information

This article is maintained by: Elsevier

Article Title: The emerging role of anti-thymic stromal lymphopoietin monoclonal antibody (Tezepelumab) in comorbid and non-comorbid CRSwNP patients: a scoping review

Journal Title: Brazilian Journal of Otorhinolaryngology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.bjorl.2026.101768

Content Type: article

Copyright: © 2026 Published by Elsevier España, S.L.U. on behalf of Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial.

Document is current

Any future updates will be listed below